Rainbow Equine Hospital Limited Accounts
Rainbow Equine Hospital Limited Accounts
Rainbow Equine Hospital Limited FILLETED ACCOUNTS COVER |
Company No. 08825966 | |||||||||
Rainbow Equine Hospital Limited DIRECTORS REPORT REGISTRAR |
The Directors present their report and the accounts for the year ended 31 December 2016. | |||||||||
Principal activities | |||||||||
Directors | |||||||||
The Directors who served at any time during the year were as follows: | |||||||||
J.D.C. Anderson | |||||||||
M.J. Brennan | |||||||||
I.V. Pritchard | |||||||||
J.B.C. Reed | |||||||||
Signed on behalf of the board | |||||||||
J.D.C. Anderson | |||||||||
Director | |||||||||
28 September 2017 |
Rainbow Equine Hospital Limited BALANCE SHEET REGISTRAR |
at | ||||||||||
Company No. | Notes | 2016 | 2015 | |||||||
£ | £ | |||||||||
Fixed assets | ||||||||||
Tangible assets | 2 | |||||||||
Investments | 3 | |||||||||
Current assets | ||||||||||
Stocks | 4 | |||||||||
Debtors | 5 | |||||||||
Cash at bank and in hand | ||||||||||
Creditors: Amount falling due within one year | 6 | ( | ( | |||||||
Net current assets/(liabilities) | ( | |||||||||
Total assets less current liabilities | ||||||||||
Provisions for liabilities | ||||||||||
Deferred taxation | 7 | ( | ( | |||||||
Net assets | ||||||||||
Capital and reserves | ||||||||||
Called up share capital | ||||||||||
Profit and loss account | 8 | |||||||||
Total equity | ||||||||||
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account. | ||||||||||
Approved by the board on 28 September 2017 | ||||||||||
And signed on its behalf by: | ||||||||||
I.V. Pritchard | ||||||||||
Director | ||||||||||
28 September 2017 |
Rainbow Equine Hospital Limited NOTES TO THE ACCOUNTS REGISTRAR |
for the year ended 31 December 2016 | ||||||||||||||
1 | Accounting policies | |||||||||||||
Basis of preparation | ||||||||||||||
Turnover | ||||||||||||||
Taxation | ||||||||||||||
Current tax The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the profit and loss account because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The Company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period. Deferred tax Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable temporary differences. Deferred tax assets are generally recognised for all deductible timing differences to the extent that it is probable that taxable profits will be available against which those deductible temporary differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Current or deferred tax for the year is recognised in profit or loss, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively. | ||||||||||||||
Tangible fixed assets and depreciation | ||||||||||||||
At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss. | ||||||||||||||
Leasehold land and buildings | ||||||||||||||
Plant and machinery | ||||||||||||||
Motor vehicles | ||||||||||||||
Stocks | ||||||||||||||
Trade and other debtors | ||||||||||||||
Trade and other creditors | ||||||||||||||
Leased assets | ||||||||||||||
Leases which do not transfer substantially all the risks and rewards of ownership to the Company are classified as operating leases. Assets held under finance leases are initially recognised as assets of the Company at their fair value at the inception of the lease or, if lower, at the present value of the minimum lease payments. The corresponding liability to the lessor is included in the balance sheet date as a finance lease obligation. Lease payments are apportioned between finance expenses and reduction of the lease obligation so as to achieve a constant rate of interest on the remaining balance of the liability. Finance expenses are recognised immediately in profit or loss, unless they are directly attributable to qualifying assets, in which case they are capitalised in accordance with the Company's policy on borrowing costs (see the accounting policy above). Assets held under finance leases are depreciated in the same way as owned assets. Operating lease payments are recognised as an expense on a straight-line basis over the lease term. | ||||||||||||||
Pensions | ||||||||||||||
Provisions | ||||||||||||||
Provisions are charged as an expense to the profit and loss account in the year that the Company becomes aware of the obligation, and are measured at the best estimate at balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties. When payments are eventually made, they are charged to the provision carried in the balance sheet. | ||||||||||||||
2 | Tangible fixed assets | |||||||||||||
Land and buildings | Plant and machinery | Motor vehicles | Total | |||||||||||
£ | £ | £ | £ | |||||||||||
Cost or revaluation | ||||||||||||||
At 1 January 2016 | ||||||||||||||
Additions | ||||||||||||||
At 31 December 2016 | ||||||||||||||
Depreciation | ||||||||||||||
At 1 January 2016 | ||||||||||||||
Charge for the year | ||||||||||||||
At 31 December 2016 | ||||||||||||||
Net book values | ||||||||||||||
At 31 December 2016 | ||||||||||||||
At 31 December 2015 | ||||||||||||||
3 | Investments | |||||||||||||
Investment in Joint venture | Total | |||||||||||||
£ | £ | |||||||||||||
Cost or valuation | ||||||||||||||
At 1 January 2016 | ||||||||||||||
At 31 December 2016 | ||||||||||||||
Net book values | ||||||||||||||
At 31 December 2016 | ||||||||||||||
At 31 December 2015 | ||||||||||||||
4 | Stocks | |||||||||||||
2016 | 2015 | |||||||||||||
£ | £ | |||||||||||||
Raw materials and consumables | ||||||||||||||
5 | Debtors | |||||||||||||
2016 | 2015 | |||||||||||||
£ | £ | |||||||||||||
Trade debtors | ||||||||||||||
Loan owed by Participating interest | ||||||||||||||
Prepayments and accrued income | ||||||||||||||
6 | Creditors: | |||||||||||||
amounts falling due within one year | ||||||||||||||
2016 | 2015 | |||||||||||||
£ | £ | |||||||||||||
Trade creditors | ||||||||||||||
Corporation tax | ||||||||||||||
Other taxes and social security | ||||||||||||||
Loans from directors | ||||||||||||||
Accruals and deferred income | ||||||||||||||
7 | Provisions for liabilities | |||||||||||||
Deferred taxation | ||||||||||||||
Accelerated capital allowances, losses and other timing differences | Arising from revaluation | Total | ||||||||||||
£ | £ | £ | ||||||||||||
At 1 January 2016 | 105,805 | |||||||||||||
Charge to the profit and loss account for the period | (26,400) | ( | ||||||||||||
At 31 December 2016 | 79,405 | |||||||||||||
2016 | 2015 | |||||||||||||
£ | £ | |||||||||||||
Accelerated capital allowances | ||||||||||||||
8 | Reserves | |||||||||||||
9 | Dividends | |||||||||||||
2016 | 2015 | |||||||||||||
£ | £ | |||||||||||||
Dividends for the period: | ||||||||||||||
Dividends paid in the period | 288,000 | 252,000 | ||||||||||||
Dividends by type: | ||||||||||||||
Equity dividends | ||||||||||||||
288,000 | 252,000 | |||||||||||||
10 | Related party disclosures | |||||||||||||
2016 | 2015 | |||||||||||||
Transactions with related parties | £ | £ | ||||||||||||
Name of related party | ||||||||||||||
Description of relationship between the parties | This is a joint venture and Rainbow Equine Hospital Ltd owns 50% of the issued share capital | |||||||||||||
Description of transaction and general amounts involved | ||||||||||||||
Amount due from/(to) the related party | ||||||||||||||
Controlling parties | ||||||||||||||
Immediate controlling parties | I V Pritchard, J D C Anderson M J Brennan, J B C Reed | |||||||||||||
11 | Additional information | |||||||||||||
Its registered number is: | ||||||||||||||
Its registered office is: | ||||||||||||||